Position in IRWD
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$558,869
-$20,610 QoQ
Shares Held
132,748
-19.6% QoQ
Ownership
0.080%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#79
of 212 holders
Holding Since
Jun 2023
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in IRWD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026FIFTH THIRD BANCORP holds $131,747,740 across 34 Drug Manufacturers - Specialty & Generic names. IRWD ranks #18 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
158,184 | $85,708,836 | |
| 2 | ZTS |
Zoetis Inc.
|
112,370 | $8,074,908 | |
| 3 | ELAN |
Elanco Animal Health Inc
|
288,888 | $7,109,533 | |
| 4 | VTRS |
Viatris Inc
|
411,537 | $6,535,207 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
|
30,217 | $5,092,773 | |
| 6 | PBH |
Prestige Consumer Healthcare Inc.
|
59,330 | $2,804,529 | |
| 7 | LQDA |
Liquidia Corp
|
35,159 | $2,803,227 | |
| 8 | HLN |
Haleon plc
|
217,576 | $2,029,984 |
All Filings in IRWD
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $558,869 | 132,748 | Shares | Defined | 2026-08-05 | |
| 2026-03-31 | $579,479 | 165,094 | Shares | Defined | 2026-05-01 | |
| 2024-12-31 | $14,911 | 3,366 | Shares | Defined | 2025-01-21 | |
| 2024-09-30 | $5,941 | 1,442 | Shares | Defined | 2024-10-17 | |
| 2024-06-30 | $9,747 | 1,495 | Shares | Defined | 2024-07-22 | |
| 2024-03-31 | $148 | 17 | Shares | Defined | 2024-04-23 | |
| 2023-12-31 | $2,425 | 212 | Shares | Defined | 2024-01-19 | |
| 2023-09-30 | $2,590 | 269 | Shares | Defined | 2023-10-31 | |
| 2023-06-30 | $5,266 | 495 | Shares | Defined | 2023-07-26 | |
| No filing history on record for this holder in this stock. | ||||||